Cambridge, United Kingdom

Emma Sharp

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • London, GB (2021)
  • Cambridge, GB (2016 - 2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Emma Sharp: A Pioneer in Pharmaceutical Innovations

Introduction

Emma Sharp, an accomplished inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 10 patents, her work primarily focuses on developing innovative compounds that address critical medical conditions.

Latest Patents

Among her latest patents, one notable invention is the crystalline PPARδ agonist. This patent describes crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, which is utilized in the preparation of pharmaceutical compositions intended for treating diseases or conditions benefiting from PPARδ agonist administration. Another significant patent involves new solid forms of a plasma kallikrein inhibitor. This involves the compound 1-({4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)pyrazole-4-carboxamide and its salts, which represent advancements in therapeutic agents.

Career Highlights

Emma has built her career working with prominent companies in the pharmaceutical industry, including Intercept Pharmaceuticals, Inc. and Reneo Pharmaceuticals, Inc. Her work within these organizations has helped to shape her innovative research and drive impactful developments in drug discovery.

Collaborations

Throughout her career, Emma has collaborated with esteemed colleagues such as André Steiner and Heidi Waenerlund Poulsen. These partnerships have facilitated the exchange of knowledge and ideas, fostering an environment ripe for innovation and advancements in pharmaceutical science.

Conclusion

Emma Sharp stands out as a progressive inventor in the pharmaceutical domain. Her dedication to developing novel compounds and her extensive patent portfolio underscore her commitment to improving healthcare solutions. Through her efforts and collaborations, Emma continues to influence the future of medicine, making substantial contributions to the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…